Alto Neuroscience, Inc. (ANRO) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailGet Alerts ANRO Hot Sheet
Join SI Premium – FREE
Alto Neuroscience, Inc. (NYSE: ANRO) reported Q1 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ACNB Corporation (ACNB) Tops Q3 EPS by 8c
- VSee Health addresses Nasdaq delisting, outlines path to profitability
- Webull launches extended-hours options trading for U.S. customers
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
